Vergis, Kelly Grace L.

HRN: 02-68-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2023
CEFUROXIME 1.5GM (VIAL)
05/21/2023
05/28/2023
IVTT
1.5g
Q8
Cap Mr, Pregnant
Waiting Final Action 
05/24/2023
AZITHROMYCIN 500MG TABLET (TAB)
05/24/2023
05/31/2023
PO
500mg Tab
OD
CAP
Checking Final Appropriateness 
09/08/2023
AMPICILLIN 1GM (VIAL)
09/08/2023
09/14/2023
IV
2g
Q6
PROM
Checking Final Appropriateness 
09/08/2023
CEFUROXIME 1.5GM (VIAL)
09/08/2023
09/14/2023
IV
1.5g
Q8h
S/p CS
Checking Final Appropriateness 
09/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2023
09/14/2023
IV
500mg
Q8h
S/p 1 LTCS
Checking Final Appropriateness 
09/10/2023
CEFUROXIME 500MG (TAB)
09/10/2023
09/16/2023
PO
500
BID
Cs
Waiting Final Action 
09/10/2023
METRONIDAZOLE 500MG (TAB)
09/10/2023
09/16/2023
PO
500
TID
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: